<<

Representative Legal Matters Piotr (Pete) Korzynski Since joining the Firm, Pete has worked on the following representative matters:

 Represented Bayer AG in its acquisition of Asklepios BioPharmaceutical, Inc., a private gene therapy company, in a transaction valued at up to USD 4 billion, including potential milestone payments.

 Represented H. Lundbeck A/S in its acquisition of Alder Biopharmaceuticals, Inc., a company focused on migraine treatment and prevention, in a transaction valued at USD 1.95 billion in cash and contingent value rights.

 Represented LVMH Moët Hennessy Louis Vuitton SE in its acquisition of Belmond Ltd., owner, part-owner or manager of 45 luxury hotel, restaurant, train and river cruise properties, in a transaction with an enterprise value of USD 3.2 billion.

 Represented Archer Daniels Midland Company in its EUR 1.5 billion acquisition of Neovia, a global provider of animal nutrition solutions.

 Represented Donaldson Company, Inc. in its proposed sale of an auto filtration business division to a buyer.

 Represented Indra Sistemas, S.A. in its acquisition of a private company focused on energy transmission software and services. Prior to joining the Firm, Pete worked on the following representative matters:

 Represented Ball Corporation in its USD 8.4 billion acquisition of Rexam PLC and its related divestiture of USD 3.42 billion in assets to Ardagh Group S.A.

 Represented The Hillshire Brands Company in its proposed USD 6.6 billion acquisition of Pinnacle Foods Inc. and subsequent USD 8.55 billion sale in an unsolicited and contested transaction to Tyson Foods, Inc.

 Represented Energy Corporation in its USD 5.7 billion acquisition of , Inc.

 Represented Horizon Pharma Public Limited Company in its unsolicited USD 2.26 billion tender offer to acquire Depomed, Inc.

 Represented Stryker Corporation in its USD 1.65 billion acquisition of MAKO Surgical Corp. and its USD 664 million acquisition of Entellus Medical, Inc.

 Represented Digital River Inc. in its USD 840 million sale to an investor group led by Siris Capital Partners.

 Represented Ecolab Inc. in its acquisition of Swisher Hygiene, Inc.

1

 Represented Corporation in its offering of USD 750 million in 3.950% subordinated notes due 2025.

 Represented CF Industries, Inc. in its offering of USD 500 million of 3.400% senior secured notes due 2021 and USD 750 million of 4.500% senior secured notes due 2026.

 Represented Morgan Stanley as the lead underwriter in , Inc.’s offering of USD 350 million of 5.2% notes due 2020 and USD 350 million of 5.8% notes due 2023.

 Represented in its offering of USD 150 million of 7.375% subordinated debentures due 2054.

 Represented pro bono clients on various amicus briefs and asylum appeals such as Ferreira v. Lynch, 831 F.3d 803 (7th Cir. 2016) (clarifying that adverse credibility findings against asylum applicants may not be based on trivial inconsistencies or unreliable preliminary interviews).

2